Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription 23.10.2023 9 AIDS 1 Am J Med 2 Antimicrob Agents Chemother 1 Blood 1 Cell 3 HIV Med 18 J Acquir Immune Defic Syndr 1 J Immunol 2 J Med Virol 2 J Virol 1 MMWR Morb Mortal Wkly Rep 1 Nature 1 Pediatr Infect Dis J 9 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. ZINCK MJ, Minichiello SN, Fick CA, Sawry S, et al
   Virtual case management: a differentiated approach to HIV prevention, treatment, and care.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003762.
   PubMed        
   
   
2. LAI M, Madden E, Shlipak MG, Scherzer R, et al
   Association of urine biomarkers of kidney health with subclinical cardiovascular disease in a MACS substudy.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003761.
   PubMed         Abstract available
   
   
3. MPEBE GGA, Phinius BB, Mutenga S, Baruti K, et al
   Hepatitis B surface antigen loss in chronic hepatitis B virus and HIV-1 Co-Infections individuals in Botswana.
   AIDS. 2023 Oct 16. doi: 10.1097/QAD.0000000000003753.
   PubMed         Abstract available
   
   
4. ZHANG J, Sun Y, Chen X, Ye Y, et al
   Incidence, clearance, and factors associated with anal HPV infection among men with HIV: a cohort study in China.
   AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003755.
   PubMed         Abstract available
   
   
5. KOSS CA, Ayieko J, Kabami J, Balzer LB, et al
   Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda: a randomized trial.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003763.
   PubMed         Abstract available
   
   
6. LARTEY M, Ganu VJ, Tachi K, Yang H, et al
   Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and HBV viral suppression.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764.
   PubMed         Abstract available
   
   
7. WANG Y, Wu G, Wen Z, Lei H, et al
   HAART-related effects on morphological connectivity in HIV: an individual-level morphological brain network study.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003759.
   PubMed         Abstract available
   
   
8. BHATTACHARYA D, Guo R, Tseng CH, Emel L, et al
   Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-saharan Africa, HPTN 046- a post-hoc analysis.
   AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003752.
   PubMed         Abstract available
   
   
9. NDUKWE SO, Patel H, Shelton B, Concha-Garcia S, et al
   People with HIV at the end of life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research.
   AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003754.
   PubMed         Abstract available
   
   

   
   Am J Med

10. WORMSER GP, Schneider LM
    False Positivity of a Human Immunodeficiency Virus (HIV) Antigen/Antibody Assay for HIV p24 Antigen in Active SARS-CoV-2 Infection.
    Am J Med. 2023 Oct 12:S0002-9343(23)00617-4. doi: 10.1016/j.amjmed.2023.
    PubMed        
    
    

    
    Antimicrob Agents Chemother

11. KENGO A, Nabisere R, Gausi K, Musaazi J, et al
    Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.
    Antimicrob Agents Chemother. 2023 Oct 18:e0043023. doi: 10.1128/aac.00430.
    PubMed         Abstract available
    
    
12. KENGO A, Gausi K, Nabisere R, Musaazi J, et al
    Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin.
    Antimicrob Agents Chemother. 2023 Oct 18:e0043123. doi: 10.1128/aac.00431.
    PubMed         Abstract available
    
    

    
    Blood

13. DI CIACCIO PR, Polizzotto MN, Cwynarski K, Gerrie AS, et al
    The Influence of Immunodeficiency, Disease Features and Patient Characteristics on Survival in Plasmablastic Lymphoma.
    Blood. 2023 Oct 13:blood.2023021348. doi: 10.1182/blood.2023021348.
    PubMed         Abstract available
    
    

    
    Cell

14. WONG AC, Devason AS, Umana IC, Cox TO, et al
    Serotonin reduction in post-acute sequelae of viral infection.
    Cell. 2023 Oct 9:S0092-8674(23)01034-6. doi: 10.1016/j.cell.2023.
    PubMed         Abstract available
    
    

    
    HIV Med

15. NANYEENYA N, Nakanjako D, Makumbi F, Nakigozi G, et al
    Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
    HIV Med. 2023 Oct 18. doi: 10.1111/hiv.13568.
    PubMed         Abstract available
    
    
16. AMBROSIONI J, Levi L, Alagaratnam J, Van Bremen K, et al
    Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
    HIV Med. 2023 Oct 18. doi: 10.1111/hiv.13542.
    PubMed         Abstract available
    
    
17. DIRAJLAL-FARGO S, Jacobson DL, Yu W, Mirza A, et al
    Longitudinal changes in body fat and metabolic complications in young people with perinatally acquired HIV.
    HIV Med. 2023 Oct 16. doi: 10.1111/hiv.13566.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

18. GIOVENCO D, Pettifor A, Qayiya Y, Jones J, et al
    The acceptability, feasibility, and preliminary effectiveness of a courier HIV-treatment delivery and SMS support intervention for young people living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003332.
    PubMed         Abstract available
    
    
19. KATAREY D, Tan Y, Mourad A, Potts JR, et al
    Non-viral Liver Disease Burden in People Living with HIV and elevated transaminases: A Cross-sectional Study.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003322.
    PubMed         Abstract available
    
    
20. HILL L, Kenney S, Patel N, Yin J, et al
    Predictors of post-switch viremia in people with HIV on injectable cabotegravir/rilpivirine.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003320.
    PubMed         Abstract available
    
    
21. RUDOLPH JE, Calkins K, Xu X, Wentz E, et al
    Comparing cancer incidence in an observational cohort of Medicaid beneficiaries with and without HIV, 2001-2015.
    J Acquir Immune Defic Syndr. 2023 Oct 9. doi: 10.1097/QAI.0000000000003318.
    PubMed         Abstract available
    
    
22. ISLAM MH, Shrestha RK, Hoch JS, Farnham PG, et al
    Estimating the cost-effectiveness of HIV self-testing in the United States using net benefit regression.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003325.
    PubMed         Abstract available
    
    
23. SHRESTHA RK, Hecht J, Chesson HW
    Analyzing the costs and impact of the TakeMeHome program, a public-private partnership to deliver HIV self-test kits in the United States.
    J Acquir Immune Defic Syndr. 2023 Oct 12. doi: 10.1097/QAI.0000000000003323.
    PubMed         Abstract available
    
    
24. LOGIE CH, Shannon K, Braschel M, Krusi A, et al
    Brief Report: Social Factors Associated With Trajectories of HIV-Related Stigma and Everyday Discrimination Among Women Living With HIV in Vancouver, Canada: Longitudinal Cohort Findings.
    J Acquir Immune Defic Syndr. 2023;94:190-195.
    PubMed         Abstract available
    
    
25. RANSOME Y, Taggart T, Huang AS, Vermund SH, et al
    Increasing Spiritual Beliefs are Associated With Lower HIV Incidence Among Black Men Who Have Sex With Men: Results From HPTN 061 Longitudinal Study.
    J Acquir Immune Defic Syndr. 2023;94:196-202.
    PubMed         Abstract available
    
    
26. BANERJEE T, Frongillo EA, Turan JM, Sheira LA, et al
    Association of Higher Intake of Plant-Based Foods and Protein With Slower Kidney Function Decline in Women With HIV.
    J Acquir Immune Defic Syndr. 2023;94:203-210.
    PubMed         Abstract available
    
    
27. BILLICK MJ, Fisher KN, Myers S, Tan DHS, et al
    Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada.
    J Acquir Immune Defic Syndr. 2023;94:211-213.
    PubMed         Abstract available
    
    
28. MEYERS K, Quigee D, Zucker J, Carnevale C, et al
    The Index of Engagement in PrEP Care: Evaluation of Psychometric Properties and Predictive Potential.
    J Acquir Immune Defic Syndr. 2023;94:214-219.
    PubMed         Abstract available
    
    
29. MCLAUGHLIN A, Lin N, Jiang W, Lodi S, et al
    Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia.
    J Acquir Immune Defic Syndr. 2023;94:244-252.
    PubMed         Abstract available
    
    
30. RODRIGUEZ VJ, Alcaide ML, Sued O, Aristegui I, et al
    Detection of Antiretrovirals in Transgender Women With HIV Is Not Altered by Hair Treatments.
    J Acquir Immune Defic Syndr. 2023;94:e3-e5.
    PubMed        
    
    
31. STENBERG E, Carlander C, Cao Y, Ottosson J, et al
    Metabolic and Bariatric Surgery for People Living With HIV-A Propensity-Matched Cohort Study.
    J Acquir Immune Defic Syndr. 2023;94:e5-e8.
    PubMed        
    
    
32. BOUSMAH MA, Protopopescu C, Mpoudi-Etame M, Omgba Bassega P, et al
    Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).
    J Acquir Immune Defic Syndr. 2023;94:262-272.
    PubMed         Abstract available
    
    
33. BAIM-LANCE A, Addison D, Archer N, Gordon P, et al
    Integrating a Resilience Framework to Assess Implementation of a Novel HIV Care Re-engagement Model in NYC.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003285.
    PubMed         Abstract available
    
    
34. MAHTAB S, Frigati LJ, Ntusi NAB, Nyathi M, et al
    The Determinants of Elevated Pathobiological Determination of Atherosclerosis in Youth risk score in Perinatally HIV Infected Adolescents in South Africa.
    J Acquir Immune Defic Syndr. 2023 Oct 18. doi: 10.1097/QAI.0000000000003304.
    PubMed         Abstract available
    
    
35. VELEZ-DIAZ-PALLARES M, Silveira ED, Fradejas JF, Llorente BM, et al
    Potentially inappropriate prescribing in older people living with HIV: A scoping review.
    J Acquir Immune Defic Syndr. 2023 Oct 16. doi: 10.1097/QAI.0000000000003298.
    PubMed         Abstract available
    
    

    
    J Immunol

36. KING HAD, Pokkali S, Kim D, Brammer D, et al
    Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques.
    J Immunol. 2023 Oct 20:ji2300424. doi: 10.4049/jimmunol.2300424.
    PubMed         Abstract available
    
    

    
    J Med Virol

37. OOMEN PGA, Dijkstra S, Hofstra LM, Nijhuis MM, et al
    Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study.
    J Med Virol. 2023;95:e29178.
    PubMed         Abstract available
    
    
38. KOWALSKI J, Cielniak I, Garbacz-Lagozna E, Cholewinska-Szymanska G, et al
    Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe.
    J Med Virol. 2023;95:e29172.
    PubMed         Abstract available
    
    

    
    J Virol

39. PADRON A, Prakash P, Pandhare J, Luban J, et al
    Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.
    J Virol. 2023 Oct 16:e0073223. doi: 10.1128/jvi.00732.
    PubMed         Abstract available
    
    
40. BARTON K, Ferguson JM, Deveson IW, Falcinelli SD, et al
    HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women.
    J Virol. 2023 Oct 16:e0070523. doi: 10.1128/jvi.00705.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

41. HOFMEISTER MG, Gupta N
    Preventable Deaths During Widespread Community Hepatitis A Outbreaks - United States, 2016-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1128-1133.
    PubMed         Abstract available
    
    

    
    Nature

42. 
    Hope rises that a vaccine can shield people with HIV from a deadly threat.
    Nature. 2023 Oct 18. doi: 10.1038/d41586-023-03220.
    PubMed        
    
    

    
    Pediatr Infect Dis J

43. BELL HL, Santos R, Varshney N, Camacho-Gomez S, et al
    Sarcina ventriculi of the Esophagus and Stomach in a Pediatric Patient With Severe Gastroparesis.
    Pediatr Infect Dis J. 2023 Oct 17. doi: 10.1097/INF.0000000000004131.
    PubMed        
    
    

    
    PLoS One

44. SENTEZA I, Castelnuovo B, Mukunya D, Makumbi F, et al
    Virological non-suppression among adult males attending HIV care services in the fishing communities in Bulisa district, Uganda.
    PLoS One. 2023;18:e0293057.
    PubMed         Abstract available
    
    
45. LISBOA C, Stuardo V, Folch C
    Sexualized drug use among gay men and other men who have sex with men in Latin America: A description of the phenomenon based on the results of LAMIS-2018.
    PLoS One. 2023;18:e0287683.
    PubMed         Abstract available
    
    
46. ANTON-VAZQUEZ V, Mnzava D, Okuma J, Mlembe S, et al
    Improving anaemia diagnosis using peripheral blood smear with remote interpretation in adults living with HIV with moderate to severe anaemia: A prospective study nested within the Kilombero and Ulanga antiretroviral cohort.
    PLoS One. 2023;18:e0293084.
    PubMed         Abstract available
    
    
47. FU J, Dai Z, Wang H, Si M, et al
    Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
    PLoS One. 2023;18:e0293297.
    PubMed         Abstract available
    
    
48. AYINDE O, Ross JDC, Jackson L
    Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    PLoS One. 2023;18:e0292273.
    PubMed         Abstract available
    
    
49. MLUNDE LB, Hirschhorn LR, Nyblade L, Rothrock NE, et al
    Translation and cultural adaptation of drug use stigma and HIV stigma measures among people who use drugs in Tanzania.
    PLoS One. 2023;18:e0292642.
    PubMed         Abstract available
    
    
50. CHANDLER R, Guillaume D, Francis S, Xue E, et al
    "I care about sex, I care about my health": A mixed-methods pre-test of a HIV prevention mobile health app for Black women in the southern United States.
    PLoS One. 2023;18:e0289884.
    PubMed         Abstract available
    
    
51. BENNETT CL, Detsky AS, Clay CE, Espinola JA, et al
    Comparison of US emergency departments by HIV priority jurisdiction designation: A case for geographically targeted screening in teaching hospitals.
    PLoS One. 2023;18:e0292869.
    PubMed         Abstract available
    
    
52. MERRILL KG, Frimpong C, Burke VM, Abrams EA, et al
    "Project YES! has given me a task to reach undetectable": Qualitative findings from a peer mentoring program for youth living with HIV in Zambia.
    PLoS One. 2023;18:e0292719.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

53. KUMAR MR, Fray EJ, Bender AM, Zitzmann C, et al
    Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir.
    Proc Natl Acad Sci U S A. 2023;120:e2313209120.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.